Zentalis Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:ZNTL) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 44.05 M39.7 M32.64 M34.71 M26.96 M 134.01 M Cash from investing activities 48.24 M32.28 M40.48 M30.38 M28.32 M 131.46 M Cash from financing activities 92 K0189 K0115 K 304 K Free cash flow 44.05 M39.7 M32.64 M34.71 M26.96 M 134.01 M

Notizie

Zentalis Pharma CEO Eastland sells $21k in shares

Zentalis Pharma CMO Bruns sells $7998 in stock

Zentalis Pharmaceuticals: PAO vende azioni per 7.800 dollari

Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)

Obiettivo di prezzo di Zentalis Pharmaceuticals ridotto a $2 da Leerink Partners

Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners

Zentalis to present azenosertib data at cancer therapeutics conference

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress